Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Child Adolesc Psychopharmacol ; 11(3): 239-50, 2001.
Article in English | MEDLINE | ID: mdl-11642474

ABSTRACT

OBJECTIVE: The goal of this study was to assess the effectiveness and tolerability of olanzapine in the treatment of acute mania in children and adolescents. METHODS: This was an 8-week, open-label, prospective study of olanzapine monotherapy (dose range 2.5-20 mg/day) involving 23 bipolar youths (manic, mixed, or hypomanic; 5-14 years old). Weekly assessments were made using the Young Mania Rating Scale (YMRS), Clinical Global Impressions Severity Scale (CGI-S), Brief Psychiatric Rating Scale, and Children's Depression Rating Scale. Adverse events were assessed through self-reports, vital sign and weight monitoring, laboratory analytes, and extrapyramidal symptom rating scales (Barnes Akathisia Scale, Simpson-Angus Scale, and Abnormal Involuntary Movement Scale). RESULTS: Twenty-two of the 23 youths (96%) completed the study. Olanzapine treatment was associated with significant improvement in mean YMRS score (-19.0 +/- 9.2, p < 0.001). Using predefined criteria for improvement of > or = 30% decline in the YMRS and a CGI-S Mania score of < or = 3 at endpoint, the overall response rate was 61%. Overall, olanzapine was well tolerated, and extrapyramidal symptom measures were not significantly different from baseline. Body weight increased significantly over the study (5.0 +/- 2.3 kg, p < 0.001). CONCLUSIONS: Open-label olanzapine treatment was efficacious and well tolerated in the treatment of acute mania in youths with bipolar disorder. Future placebo-controlled, double-blind studies are warranted.


Subject(s)
Antipsychotic Agents/therapeutic use , Bipolar Disorder/drug therapy , Pirenzepine/analogs & derivatives , Pirenzepine/therapeutic use , Abdominal Pain/chemically induced , Adolescent , Antipsychotic Agents/adverse effects , Appetite/drug effects , Benzodiazepines , Brief Psychiatric Rating Scale , Child , Child, Preschool , Disorders of Excessive Somnolence/chemically induced , Female , Humans , Male , Olanzapine , Patient Compliance , Pirenzepine/adverse effects , Prospective Studies , Severity of Illness Index , Time Factors , Weight Gain/drug effects
2.
Harv Rev Psychiatry ; 8(4): 192-8, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11038344

ABSTRACT

With the goal of evaluating the available literature on the course of Tourette's disorder, we conducted a systematic literature search through electronic databases for pertinent scientific articles in English with a minimum of 20 subjects. We also examined bibliographies of papers identified in this manner for additional sources. We found only 16 articles; most consisted of retrospective reports on treated samples. Overall, the available literature suggests that Tourette's disorder follows a remitting course in a sizeable number of individuals. Little has been published regarding predictors of remission or persistence. More work is needed using longitudinal prospective studies to better define the course and outcome of Tourette's disorder.


Subject(s)
Tourette Syndrome/drug therapy , Tourette Syndrome/epidemiology , Adolescent , Adult , Antipsychotic Agents/therapeutic use , Child , Comorbidity , Disease Progression , Europe/epidemiology , Haloperidol/therapeutic use , Humans , Middle Aged , North America/epidemiology , Tourette Syndrome/therapy , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...